abrdn Life Sciences Investors Shares of Beneficial Interest (HQL) at a glance

abrdn Life Sciences Investors Shares of Beneficial Interest (HQL) is a small-cap Financial Services company. It trades at $20.66, with a P/E of 2.6, a 17857% profit margin and revenue decline of 60.8%. It pays a 12% dividend yield. Vestovix scores it 70/100 overall. Its strongest dimension is Value (99/100) and its weakest is Growth (12/100). Its volatility is roughly in line with the market.

Price
$20.66
Market cap
$515.4M
P/E ratio
2.6
Dividend yield
11.96%
Beta
0.73
52-week range
$13.88 to $22.67
Vestovix Score70/ 100How this works
Value
99
Growth
12
Income
97
Safety
80
Momentum
70

Other Financial Services stocks

See all